scholarly journals Endoscopic tumor resection of the inferior vena cava

2006 ◽  
Vol 132 (3) ◽  
pp. 687-688 ◽  
Author(s):  
H. Jeanmart ◽  
P. Lecompte ◽  
F. Casselman ◽  
J. Coddens ◽  
G. Van Vaerenberg ◽  
...  
2020 ◽  
Vol 21 (Supplement_1) ◽  
Author(s):  
K Diniz Ferrer ◽  
CARLOS Silveira ◽  
ADRIAN Reis ◽  
PAULA Abreu E Lima ◽  
ROBERT Diniz ◽  
...  

Abstract Funding Acknowledgements governmental grants Uterine leiomyoma is a commom disease in women, however, intravenous leiomyomatosis of uterine origin extending via inferior vena cava into the right side of the heart,known as intracardiac leiomyomatosis is a rare condition (3%). In 1907, Durk reported the first case of intracardiac extension. The patient was a Woman, 35 years old, admitted to our emergency department for an intracardiac mass. She had shortness of breath,fatigue and chest pain. The transthoracic two dimensional echocardiography showed an echogenic oval mass mobile in right atrium and projected through right ventricle in diastole. This mass was observed to extend from inferior vena cava to the right atrium. The echotransesophageal three dimensional showed a large mobile mass that extended from inferior vena cava to the right atrium. A Computer tomographic (CT) scan showed a hypodense multilobulated mass in the pelvis, which had invaded the inferior vena cava and right atrium. The patient underwent a two stages surgery. In first stage (transatrial tumor resection). The operation was performed normal temperature with establisment of cardiopulmonary bypass (CPB). Subsequently, the pathological report was confirmed uterin smooth muscle origin. The second stage surgery ( total histerectomy) was done four weeks later for removing lobulated mass uterin with dimensions 20x15x7.5cm with confirmed histopathological of leiomyoma. Because of it is nonspecific clinical presentation and rarity, an intracardiac Leiomyomatosis continues to be a misdiagnosed as either thrombus or myxoma. The cardiac imaging techniques like a transthoracic echocardiography 2d and transesophageal echocardiography 3d have been used to define the presence, extension of tumor as appearance of the mass and involvement of adjacent structures. Abstract P169 Figure. Echotransesophageal 3D (bicaval view)


2015 ◽  
Vol 61 (6) ◽  
pp. 88S
Author(s):  
Lidie Lajoie ◽  
Ajay Dhadwal ◽  
Joe Huang ◽  
Frank Padberg ◽  
Michael Curi

2016 ◽  
Vol 9 (3) ◽  
pp. 599-609 ◽  
Author(s):  
Shuichi Fujita ◽  
Hideaki Takahashi ◽  
Yumiko Kanzaki ◽  
Tomohiro Fujisaka ◽  
Yoshihiro Takeda ◽  
...  

A 38-year-old woman had developed an abdominal distention, lower extremity edema, and dyspnea. Imaging examination revealed a large mass in the right atrium which was connected to lesions within the inferior vena cava. Although complete resection of the mass was not possible, partial surgical tumor resection was performed to avoid pulmonary embolization and circulatory collapse. Leiomyosarcoma was diagnosed histologically, and chemotherapy (doxorubicin) followed by radiotherapy was started. By reviewing papers published in the past 10 years that included 322 patients, we also discuss the clinical presentations and prognosis of leiomyosarcoma in the inferior vena cava.


1999 ◽  
Vol 13 (1) ◽  
pp. 69-71 ◽  
Author(s):  
Jerome F. O'Hara ◽  
Juraj Sprung ◽  
David Whalley ◽  
Brenda Lewis ◽  
Giorgio Zanettin ◽  
...  

2019 ◽  
Vol 5 (1) ◽  
Author(s):  
Shuhei Miura ◽  
Akira Yamada ◽  
Yutaka Iba ◽  
Ryushi Maruyama ◽  
Eiichiro Hatta ◽  
...  

Abstract Background Cardiac metastasis from renal cell carcinoma is an exceptional event, particularly when there is lack of inferior vena cava involvement. Only a few cases have been reported worldwide so far. Case presentation We presented a case of a 58-year-old man diagnosed with isolated right ventricular metastasis of renal cell carcinoma in the absence of direct inferior vena cava extension, who underwent surgical tumor resection using cardiopulmonary bypass. Conclusions Surgical resection of the cardiac mass with an understanding of the pathology is needed to prevent sudden death from acute heart failure or tumor embolism and improve the patient’s quality of life.


2019 ◽  
Vol 12 (2) ◽  
pp. 243-245
Author(s):  
Cesar Cuen-Ojeda ◽  
Jesus H. Rivera-Banuelos ◽  
Javier E. Anaya-Ayala ◽  
Carlos A. Hinojosa

Sign in / Sign up

Export Citation Format

Share Document